Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neelu Puri

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Biochemical and Biophysical Research Communications|July 12, 2016
Mechanism of c-Met and EGFR tyrosine kinase inhibitor resistance through epithelial mesenchymal transition in non-small cell lung cancerIchwaku Rastogi, Supriya Rajanna, Andrew Webb, et al.
Antioxidants (Basel, Switzerland)|February 21, 2017
Treating Cancer by Targeting Telomeres and TelomeraseMarko Ivancich, Zachary Schrank, Luke Wojdyla, et al.
Experimental Cell Research|May 25, 2002
Induction of apoptosis by telomere 3' overhang-specific DNAMark S Eller, Neelu Puri, Ina M Hadshiew, et al.
Biochemical and Biophysical Research Communications|January 17, 2018
Comparison of EMT mediated tyrosine kinase inhibitor resistance in NSCLCTsatsral Iderzorig, Joseph Kellen, Chike Osude, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 31, 2004
Telomere-based DNA damage responses: a new approach to melanomaNeelu Puri, Mark S Eller, H Randolph Byers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
c-Met is a potentially new therapeutic target for treatment of human melanomaNeelu Puri, Salman Ahmed, Varalakshmi Janamanchi, et al.
International Journal of Nanomedicine|January 7, 2014
Novel delivery system for T-oligo using a nanocomplex formed with an alpha helical peptide for melanoma therapySrijayaprakash B Uppada, Terrianne Erickson, Luke Wojdyla, et al.
Cancer Research|April 19, 2007
A selective small molecule inhibitor of c-Met, PHA665752, inhibits tumorigenicity and angiogenesis in mouse lung cancer xenograftsNeelu Puri, Andrey Khramtsov, Salman Ahmed, et al.
Biochemical and Biophysical Research Communications|March 18, 2014
T-oligo as an anticancer agent in colorectal cancerLuke Wojdyla, Amanda L Stone, Nan Sethakorn, et al.
Molecules (Basel, Switzerland)|September 8, 2018
Oligonucleotides Targeting Telomeres and Telomerase in CancerZachary Schrank, Nabiha Khan, Chike Osude, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Biochemical and Biophysical Research Communications|July 12, 2016
Mechanism of c-Met and EGFR tyrosine kinase inhibitor resistance through epithelial mesenchymal transition in non-small cell lung cancerIchwaku Rastogi, Supriya Rajanna, Andrew Webb, et al.
Antioxidants (Basel, Switzerland)|February 21, 2017
Treating Cancer by Targeting Telomeres and TelomeraseMarko Ivancich, Zachary Schrank, Luke Wojdyla, et al.
Experimental Cell Research|May 25, 2002
Induction of apoptosis by telomere 3' overhang-specific DNAMark S Eller, Neelu Puri, Ina M Hadshiew, et al.
Biochemical and Biophysical Research Communications|January 17, 2018
Comparison of EMT mediated tyrosine kinase inhibitor resistance in NSCLCTsatsral Iderzorig, Joseph Kellen, Chike Osude, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 31, 2004
Telomere-based DNA damage responses: a new approach to melanomaNeelu Puri, Mark S Eller, H Randolph Byers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
c-Met is a potentially new therapeutic target for treatment of human melanomaNeelu Puri, Salman Ahmed, Varalakshmi Janamanchi, et al.
International Journal of Nanomedicine|January 7, 2014
Novel delivery system for T-oligo using a nanocomplex formed with an alpha helical peptide for melanoma therapySrijayaprakash B Uppada, Terrianne Erickson, Luke Wojdyla, et al.
Cancer Research|April 19, 2007
A selective small molecule inhibitor of c-Met, PHA665752, inhibits tumorigenicity and angiogenesis in mouse lung cancer xenograftsNeelu Puri, Andrey Khramtsov, Salman Ahmed, et al.
Biochemical and Biophysical Research Communications|March 18, 2014
T-oligo as an anticancer agent in colorectal cancerLuke Wojdyla, Amanda L Stone, Nan Sethakorn, et al.
Molecules (Basel, Switzerland)|September 8, 2018
Oligonucleotides Targeting Telomeres and Telomerase in CancerZachary Schrank, Nabiha Khan, Chike Osude, et al.
Pageof 4